17.54
1.95%
0.335
After Hours:
17.54
Pulse Biosciences Inc stock is traded at $17.54, with a volume of 201.09K.
It is up +1.95% in the last 24 hours and down -5.90% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
See More
Previous Close:
$17.20
Open:
$17.19
24h Volume:
201.09K
Relative Volume:
0.88
Market Cap:
$1.08B
Revenue:
-
Net Income/Loss:
$-42.21M
P/E Ratio:
-14.38
EPS:
-1.22
Net Cash Flow:
$-33.16M
1W Performance:
+1.27%
1M Performance:
-5.90%
6M Performance:
+101.38%
1Y Performance:
+335.24%
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-27-21 | Initiated | Stephens | Overweight |
Mar-11-21 | Initiated | Maxim Group | Buy |
Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Bank of New York Mellon Corp Buys 9,639 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - MarketBeat
Pulse Biosciences Inc [PLSE] Investment Appeal on the Rise - Knox Daily
How To Trade (PLSE) - Stock Traders Daily
Metric Deep Dive: Understanding Pulse Biosciences Inc (PLSE) Through its Ratios - The Dwinnex
Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.4% - Defense World
Inspire Investing LLC Sells 8,725 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Upgraded by StockNews.com to "Sell" - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Upgraded to “Sell” at StockNews.com - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - Defense World
Quest Partners LLC Purchases New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $18.51 - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Down 2.7% - MarketBeat
Keeping an Eye on Pulse Biosciences Inc (PLSE) After Insider Trading Activity - Knox Daily
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7% - MarketBeat
Paul LaViolette Joins Pulse Bioscience's Board Of Directors - MPO-mag
Pulse Biosciences (NASDAQ:PLSE) Trading Down 9.6% - MarketBeat
Pulse Biosciences Inc (PLSE) may enjoy gains as insiders got busy in the recent days - Knox Daily
Ratios in Focus: Analyzing Pulse Biosciences Inc (PLSE)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Pulse Biosciences Inc [PLSE] Investment Guide: What You Need to Know - Knox Daily
(PLSE) Technical Data - Stock Traders Daily
Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris Therapeutics, Alma Lasers, BIOLASE, BioLineRx, DermBiont, Novartis and Pulse Biosciences - GlobeNewswire
Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris - Daily Guardian Canada
Pulse Biosciences (NASDAQ:PLSE) Trading Down 8.1% - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $19.96 - Defense World
Pulse Biosciences (NASDAQ:PLSE) Trading Up 3.9% - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Stock Quotes, Forecast and News Summary - Benzinga
PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024 - InvestorPlace
Griffin Asset Management Inc. Sells 42,641 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Reaches New 12-Month High at $21.00 - Defense World
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $19.96 - MarketBeat
Investing in Pulse Biosciences Inc (PLSE): What You Must Know - Knox Daily
Pulse Biosciences (NASDAQ:PLSE) Reaches New 52-Week High at $21.00 - MarketBeat
Pulse Biosciences stock hits 52-week high at $20.51 - Investing.com
Pulse Biosciences stock hits 52-week high at $20.51 By Investing.com - Investing.com Canada
Pulse Biosciences stock hits 52-week high at $20.51 By Investing.com - Investing.com Australia
Price T Rowe Associates Inc. MD Buys Shares of 10,009 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Cetera Advisors LLC Invests $109,000 in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Vanguard Group Inc. Buys 189,227 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Vanguard Group Inc. Increases Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 8% - MarketBeat
Taking a Closer Look At Pulse Biosciences Inc (PLSE) Following Its Recent Trade - Knox Daily
Paul LaViolette joins Pulse Biosciences as co-chairman By Investing.com - Investing.com Australia
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q2 2024 Earnings Call Transcript - Insider Monkey
Paul LaViolette joins Pulse Biosciences as co-chairman - Investing.com India
Paul LaViolette joins Pulse Biosciences as co-chairman - Investing.com
Pulse Biosciences Inc (PLSE) Q2 2024 Earnings Call Transcript Hi - GuruFocus.com
Earnings call: Pulse Biosciences details progress on nano-PFA devices By Investing.com - Investing.com Canada
Earnings call: Pulse Biosciences details progress on nano-PFA devices - Investing.com
Pulse Biosciences successfully treats first patients with nano-PFA cardiac surgery system - Cardiac Rhythm News
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):